ReviewArchives of microbiology2025
Endophytic fungi of Cynodon dactylon: a treasure trove of bioactive compounds.
Review in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cynodon dactylon (L.) Pers., commonly known as Bermuda grass, is a medicinally significant plant recognized for its diverse pharmacological properties. Recent research highlights that its association with endophytic fungi contributes to the synthesis of bioactive secondary metabolites with immense therapeutic and agricultural potential. These fungal endophytes produce a wide spectrum of bioactive compounds, including antimicrobial, antioxidant, anticancer, immunosuppressive, and plant growth-promoting agents, positioning them as valuable resources for drug discovery and sustainable biotechnological applications. Despite their vast potential, the biodiversity, metabolic pathways, and functional significance of endophytic fungi in C. dactylon remain underexplored. This review consolidates the current knowledge on the isolation, identification, and characterization of endophytic fungi from C. dactylon, emphasizing their bioactive metabolites and pharmacological significance. Furthermore, it explores their biotechnological applications and the future scope of utilizing these fungi in pharmaceutical and agricultural advancements. Understanding the metabolic potential of these fungal endophytes can open new avenues for harnessing novel bioactive compounds, contributing to the development of innovative therapeutics and eco-friendly agricultural solutions.
Indexed as
Identifiers
40349267What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.